Hydroxychloroquinsulfat Dr. Eberth (Hydroxychloroquine Sulfate)

Hydroxychloroquine sulfate accumulates in acidic cellular compartments, raising their pH and inhibiting lysosomal activity. This disrupts antigen processing, reduces cytokine production, and modulates T‑cell activation. In malaria parasites, it interferes with heme polymerisation, causing toxic heme buildup that kills the parasite.

The appropriate dose of Hydroxychloroquinsulfat is determined by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and any concomitant therapies. Dosage regimens are individualized and should follow the prescriber’s written instructions.

The safety of hydroxychloroquine sulfate in pregnancy and lactation has not been definitively established. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Hydroxychloroquinsulfat, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Hydroxychloroquinsulfat offers both antimalarial activity and immunomodulatory effects, making it useful for malaria prophylaxis and for autoimmune diseases such as rheumatoid arthritis and lupus. Compared with other DMARDs, it has a different safety profile, lacking the bone marrow suppression seen with methotrexate, but it requires monitoring for retinal toxicity and cardiac effects.

Hydroxychloroquinsulfat should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Hydroxychloroquinsulfat is administered orally, typically as a tablet that is swallowed with water. The exact timing (e.g., with or without food) should follow the prescribing clinician’s instructions to optimise absorption and minimise gastrointestinal discomfort.

The most serious risks include retinal toxicity that can lead to irreversible vision loss, cardiomyopathy or arrhythmias such as QT prolongation, and severe skin reactions like Stevens‑Johnson syndrome. Regular ophthalmologic examinations and cardiac monitoring are advised for patients on long‑term therapy.

Hydroxychloroquinsulfat is contraindicated in patients with known hypersensitivity to hydroxychloroquine or related compounds. Caution is also advised for individuals with pre‑existing retinal disease, significant cardiac conduction abnormalities, severe hepatic or renal impairment, and those taking other QT‑prolonging medications.